FDA Approves Groundbreaking Gene Therapy for Cancer – MIT Technology Review
MIT Technology Review |
FDA Approves Groundbreaking Gene Therapy for Cancer
MIT Technology Review A revolutionary cancer therapy that uses genetically engineered immune cells has been approved by the U.S. Food and Drug Administration, ushering in a new era of cancer treatment. The FDA calls the treatment, made by Novartis, the “first gene therapy … FDA approval brings first gene therapy to the United StatesFDA.gov FDA Approves First Gene Therapy For LeukemiaNPR FDA announces first US gene therapy approval for cancer treatmentCNN PBS NewsHour –National Cancer Institute all 656 news articles » |
CBS Boston / WBZ |
HealthWatch: A New Gene Therapy For Leukemia; A Study On …
CBS Boston / WBZ A so-called “living drug” that is providing new hope for some kids with cancer. The FDA has just approved CAR-T cell therapy that genetically engineers a … |
NPR |
FDA clears first gene-altering therapy — ‘a living drug’ — for childhood leukemia
Washington Post Unlike some experimental gene approaches, the Novartis treatment, called CAR T-cell therapy, doesn’t replace disease-causing genes with healthy ones. Instead, in a complicated and personalized process, white blood cells called T cells are extracted … FDA Approves First Gene Therapy For LeukemiaNPR Novartis Sets a Price of $475000 for CAR T-Cell TherapyOncLive FDA approval brings first gene therapy to the United StatesFDA.gov Science Magazine –Markets Insider –National Cancer Institute all 656 news articles » |
The Yucatan Times |
University of Yucatan launches stem cell laboratory
The Yucatan Times MERIDA — The Faculty of Dentistry of the Autonomous University of Yucatan (UADY, for its acronym in Spanish) has inaugurated its Translational Cell Laboratory, the only one of its kind in the southeast of the country, where research will be carried … |
KUNC |
FDA Approves First Gene Therapy For Leukemia
KUNC The Food and Drug Administration on Wednesday announced what the agency calls a “historic action” — the first approval of a cell-based gene therapy in the United States. The FDA approved Kymriah, which scientists refer to as a “living drug” because it … FDA approval brings first gene therapy to the United StatesFDA.gov Ben Taub Hospital – Harris Health SystemHarris Health System ‘This Is Surreal’: Houston Dialysis Center Struggles To Treat PatientsNPR NPR –National Cancer Institute all 34 news articles » |
OncLive |
Novartis Sets a Price of $475000 for CAR T-Cell Therapy
OncLive Novartis’ just-approved chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel (Kymriah) is going to be introduced on the market at a price of $475,000 for a single infusion, an amount that is within the range anticipated by oncologists and … First CAR T-Cell ‘Living Drug’ Approved by FDAMedscape FDA Approves First Gene Therapy For LeukemiaNPR FDA approves a ‘historic’ new type of leukemia treatmentToday.com MedPage Today –Scientific American –FDA.gov all 232 news articles » |
Express.co.uk |
Cancer breakthrough: Scientists hail gene therapy treatment which KILLS cancer cells
Express.co.uk CAR-T cell treatment is the first gene therapy to be made available and one of a wave of expensive custom-made “living drugs” being tested against blood cancers. The US Food and Drug Administration agency has hailed its approval as historic. |
Wall Street Journal (subscription) |
FDA Approves Pioneering Cancer Treatment With $475000 Price Tag
Wall Street Journal (subscription) The Food and Drug Administration approved a first-of-its kind cancer therapy aimed at bolstering a patient’s own immune cells, while the drugmaker behind the treatment attempted to allay worry over the high cost of the procedure. Swiss pharmaceuticals … |